dangers of glp 1 drugs Adverse effects GLP-1 class drugs. Gastrointestinal issues are It's Not an Overdose: The

Our Firm is one of the national leaders in product liability lawsuits and has decades of success winning our clients compensation

Jessica Duncan, an obesity certified MD and Chief Medical Officer at Ivim Health

Metabolic-bariatric surgery is an option for patients with MASLD or MASH and obesity, as it can promote weight loss, liver health, remission of type 2 diabetes, and reduction of cardiovascular risk

Recent study has shown that Exenatide and Liraglutide improve insulin sensitivity and lower fasting and postprandial blood glucose in T1D patients who do not make their own insulin

There is no consensus on which dietary approach is best

In the results of a cohort study published in BMJ, new users of GLP-1 receptor agonists had a 30% lower risk of severe COPD exacerbation compared to new sulfonylurea users